Use of the Pasero Opioid-induced Sedation Scale (POSS) in Pediatric Patients

Ann Quinlan-Colwell1, Gayle Thear1, Emily Miller-Baldwin1

  • 1New Hanover Regional Medical Center, 2131 South 17(th) Street, Wilmington, NC 28405, United States.

Insights

The Pasero Opioid-induced Sedation Scale (POSS) is safe and effective for assessing pediatric patient sedation. Implementing the POSS improved documentation and prevented adverse respiratory events in children receiving opioids.

Area of Science:

  • Pediatric Nursing
  • Pain Management
  • Patient Safety

Background:

  • The Pasero Opioid-induced Sedation Scale (POSS) is a validated tool for assessing opioid-induced sedation.
  • While used in pediatrics, the POSS lacked formal evaluation in this population.
  • Preventing adverse opioid-related respiratory events is crucial in pediatric care.

Purpose of the Study:

  • To evaluate the Pasero Opioid-induced Sedation Scale (POSS) in a pediatric population.
  • To compare sedation documentation and respiratory adverse events before and after POSS implementation.
  • To assess the appropriateness and safety of the POSS for pediatric patients.

Main Methods:

  • Quasi-experimental design with a convenience sample of pediatric patients.
  • Comparison of sedation documentation and adverse respiratory events pre- and post-POSS implementation.
  • Nurse surveys to evaluate the POSS's usability and safety in pediatrics.

Main Results:

  • Implementation of the POSS increased clarity and frequency of sedation documentation.
  • No opioid-related adverse respiratory events occurred after POSS implementation.
  • Nurses found the POSS easy, appropriate, and safe for pediatric use, enhancing communication.

Conclusions:

  • The Pasero Opioid-induced Sedation Scale (POSS) is appropriate and safe for assessing pediatric patient sedation.
  • POSS implementation improved documentation standards and patient safety regarding opioid use.
  • Standardized sedation assessment with POSS facilitates better interprofessional communication.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
2.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
583